Howard named UI’s first-ever National Academy of Inventors fellow
The National Academy of Inventors (NAI) has named University of Iowa neurosurgeon and entrepreneur Matthew Howard, M.D., a 2018 fellow.
Study shows AI can deliver specialty-level diagnosis in primary care setting
A system designed by a University of Iowa ophthalmologist that uses artificial intelligence (AI) to detect diabetic retinopathy without a person interpreting the results earned Food and Drug Administration (FDA) authorization in April, following a clinical trial in primary care offices. Results of that study were published Aug. 28 online in Nature Digital Medicine, offering the first look at data that led to FDA clearance for IDx-DR, the first medical device that uses AI for the autonomous detection of diabetic retinopathy.
UI ahead of curve on IP reporting requirements under new Bayh-Dole rules
University of Iowa researchers may have recently heard about new regulations related to the 1980 Bayh-Dole Act around Intellectual Property (IP) for universities that receive federal grants.
FDA to expedite review of IDx AI diagnostic system
IDx, a privately held AI diagnostics company built on University of Iowa research, announced today that it has filed its De Novo submission to the Food and Drug Administration (FDA) for IDx-DR, an AI-based system for the autonomous detection of diabetic retinopathy — a leading cause of blindness.
UI startup Voxello wins grants totaling more than $1 million
University of Iowa spinout company Voxello, which develops technologies that allow hospitalized patients to overcome communication barriers, recently received three grants to help advance its research and development.
UI makes progress on revising, streamlining intellectual property policies
Having clear and up-to-date protocols and policies around intellectual property (IP) is critically important for moving discovery at the University of Iowa forward. It ensures that inventions by faculty and staff are clearly identified, adequately protected, and leveraged in a way that benefits the inventor, the university, and the public—should the IP eventually translate into a commercial product, service, or company.
Kerbeshian named Assistant Vice President and Director of UI Research Foundation
The University of Iowa is ramping up its efforts to identify, protect, and translate promising research into commercial ventures and launch more faculty startup businesses.
UI Research Foundation licensing associate awarded Howard Bremer Scholarship
Kenneth Karanja, a licensing associate for the University of Iowa Research Foundation, was recently awarded the Howard Bremer Scholarship from the Association of University Technology Managers (AUTM). The scholarship was established to foster education opportunities for individuals who bring creativity and innovation to the academic technology transfer profession.
UI researchers discover vitamin C may offer new treatment option for multiple myeloma
Whether in the form of orange juice or a little tangy tasting pill, vitamin C is what you’re told to take when you’re feeling under the weather. University of Iowa researchers in the Holden Comprehensive Cancer Center Multiple Myeloma Program recently found evidence that mega doses of vitamin C delivered intravenously may offer new hope to people diagnosed with multiple myeloma. The results of their study were recently published in the international journal EBioMedicine.
Two UI-affiliated companies selected for Partnering for Growth’s Biotech Innovation Showcase
University of Iowa affiliated companies Behavioral Diagnostics and CartilaGen are two of a dozen emerging startup companies selected to compete at the Partnering for Growth’s Biotech Innovation Showcase on March 21 in Ankeny, Iowa. The companies selected represent a cross section of biotech industry including agricultural technology, human health, animal health and bio materials.
Pages
